If you have been reading about c-Met receptor and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-02-03. Where a claim depends on a specific study, the study is described rather than over-claimed.
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.
Most published reports on dihexa come from cell cultures and animal models. Studies have examined markers of synapse formation, dendritic spine density, and performance on learning tasks in rodents. Proposed mechanisms center on hepatocyte growth factor and its c-Met receptor, with additional attention to angiotensin IV-related pathways. These findings are experimental and have not been confirmed as clinical benefits in humans. The literature often uses different tasks and endpoints, which complicates direct comparison across studies.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
| Property | Value | Notes |
|---|---|---|
| Primary reported target | Hepatocyte growth factor/c-Met signaling | Findings mainly from cell and animal studies. |
| Related endogenous peptide | Angiotensin IV | Dihexa is described as a stabilized analog. |
| Common analytical method | Reverse-phase high-performance liquid chromatography | Used for purity assessment. |
| Identity confirmation | Mass spectrometry | Provides a molecular mass check. |
| Regulatory status | Not approved for human use | Sold as a research chemical in many jurisdictions. |
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
== Research potential == GHRH naturally declines with age. No conclusive results are known whether sermorelin could yield potential benefits for adults, such as to enhance pituitary function or mimic growth hormone secretion patterns. Orally active growth hormone-releasing peptides may be under development. Sermorelin may be an alternative to rhGH for growth hormone replacement therapy (GHRT) in aging adults. Sermorelin can be prescribed for off-label use without the legal restrictions that apply to rhGH.
The first functionally characterized de novo gene identified in mice, a noncoding RNA gene, was also described in 2009. In primates, a 2008 informatic analysis estimated that 15/270 primate orphan genes had been formed de novo. A 2009 report identified the first three de novo human genes, one of which is a therapeutic target in chronic lymphocytic leukemia. This was, however, shown to lack sufficient evidence for translation and it is regarded as a lncrna. Since this time, a plethora of genome-level studies have identified large numbers of orphan genes in many organisms, although the extent to which they arose de novo, and the degree to which they can be deemed functional, remain debated.
A coordination complex is a chemical compound consisting of a central atom or ion, which is usually metallic and is called the coordination centre, and a surrounding array of bound molecules or ions, that are in turn known as ligands or complexing agents. Many metal-containing compounds, especially those that include transition metals (elements like titanium that belong to the periodic table's d-block), are coordination complexes. Coordination complexes can have a wide variety of coordination numbers and molecular geometries, with some complexes exhibiting Jahn–Teller distortions. Additionally, most coordination complexes are colored, due to visible light absorption due to d-d transitions or charge-transfer. The two main models explaining the properties (such as electronic structure, magnetism, and color) of complexes are crystal field theory and ligand field theory.
Sources: en.wikipedia.org
studies of Gulf War veterans show that, in those who have retained fragments of depleted uranium following combat related injury, it has been possible to detect elevated urinary uranium levels, but no kidney toxicity or other adverse health effects related to depleted uranium after a decade of follow-up." Pier Roberto Danesi, then-director of the International Atomic Energy Agency (IAEA) Seibersdorf +Laboratory, stated in 2002 that "There is a consensus now that DU does not represent a health threat". The IAEA reported in 2003 that, "based on credible scientific evidence, there is no proven link between DU exposure and increases in human cancers or other significant health or environmental impacts," although "Like other heavy metals, DU is potentially poisonous. In sufficient amounts, if DU is ingested or inhaled it can be harmful because of its chemical toxicity. High concentration could cause kidney damage." The IAEA concluded that, while depleted uranium is a potential carcinogen, there is no evidence that it has been carcinogenic in humans. A 2005 study by the U.S. Sandia National Laboratories' Al Marshall used mathematical models to analyze potential health effects associated with accidental exposure to depleted uranium during the 1991 Gulf War. Marshall's study concluded that the reports of cancer risks from DU exposure are not supported by his analysis nor by veteran medical statistics. Marshall also examined possible genetic effects due to radiation from depleted uranium.
In probability theory, λ represents the density of occurrences within a time interval, as modelled by the Poisson distribution. In mathematical logic and computer science, λ is used to introduce anonymous functions expressed with the concepts of lambda calculus. λ indicates an eigenvalue in the mathematics of linear algebra. In the physics of particles, lambda indicates the thermal de Broglie wavelength In the physics of electric fields, lambda sometimes indicates the linear charge density of a uniform line of electric charge (measured in coulombs per meter). Lambda denotes a Lagrange multiplier in multi-dimensional calculus. In solid-state electronics, lambda indicates the channel length modulation parameter of a MOSFET. In ecology, lambda denotes the long-term intrinsic growth rate of a population. This value is often calculated as the dominant eigenvalue of the age/size class matrix. In formal language theory and in computer science, lambda denotes the empty string. Lambda is a nonstandard symbol in the International Phonetic Alphabet for the voiced alveolar lateral affricate [dɮ]. Lambda denotes the Lebesgue measure in mathematical set theory. The Goodman and Kruskal's lambda in statistics indicates the proportional reduction in error when one variable's values are used to predict the values of another variable. Lambda denotes the oxygen sensor in a vehicle that measures the air-to-fuel ratio in the exhaust gases of an internal-combustion engine. A Lambda 4S solid-fuel rocket was used to launch Japan's first orbital satellite in 1970.
The country had fielded black troops during World War I, but since then had retained them only within the BSAP. A nucleus of airmen existed in the form of the Southern Rhodesian Air Force (SRAF), which in August 1939 comprised one squadron of 10 pilots and eight Hawker Hardy aircraft, based at Belvedere Airport near Salisbury. The occupation of Czechoslovakia by Nazi Germany in March 1939 convinced Huggins that war was imminent. Seeking to renew his government's mandate to pass emergency measures, he called an early election in which his United Party won an increased majority. Huggins rearranged his Cabinet on a war footing, making the Minister of Justice Robert Tredgold Minister of Defence as well. The territory proposed forces not only for internal security but also for the defence of British interests overseas. Self-contained Rhodesian formations were planned, including a mechanised reconnaissance unit, but Tredgold opposed this. Remembering the catastrophic casualties suffered by units such as the Royal Newfoundland Regiment and the 1st South African Infantry Brigade on the Western Front in World War I, he argued that one or two heavy defeats for a white Southern Rhodesian brigade might cause crippling losses and have irrevocable effects on the country as a whole. He proposed to instead concentrate on training white Rhodesians for leadership roles and specialist units, and to disperse the colony's men across the forces in small groups. These ideas met with approval in both Salisbury and London and were adopted.
Sources: en.wikipedia.org
Romaine (1806), speaker of the New York State Assembly Egbert Benson (1807), member of the Board of Aldermen of New York City and 4th president of the Saint Nicholas Society of the City of New York, nephew of founding father Egbert Benson Henry H. Ross (1808), U.S. congressman from New York Peter Dumont Vroom (1808), U.S. minister to Prussia and governor of New Jersey John Fine (1809), U.S. congressman from New York John Slidell (1810), Confederate minister to France and a central figure of the Trent Affair during the American Civil War; United States senator from Louisiana, brother-in-law of Admiral Matthew C. Perry Charles G. Ferris (1811), U.S. congressman from New York Van Brugh Livingston (1811), chargé d'affaires to Ecuador Nathanael G. Pendleton (1813), U.S. congressman from Ohio Samuel L. Gouverneur (1817), postmaster of New York City, private secretary, nephew, and son-in-law of President James Monroe James I. Roosevelt (1815), U.S. congressman from New York; brother of Cornelius Roosevelt William Beach Lawrence (1818), U.S. chargé d'affaires for Great Britain and acting governor of Rhode Island William F. Havemeyer (1823), three-time mayor of New York City William Duer (1824), U.S.congressman from New York John McKeon (1825): U.S. attorney, Southern District of New York; U.S. congressman from New York Hamilton Fish (1827), US secretary of state; governor of New York; United States senator from New York John Henry Hobart Haws (1827), U.S. congressman from New York John D.
== Mythological origins == In Greek mythology, the centaur Chiron was a "Wounded Healer", after being poisoned with an incurable wound by one of Hercules's arrows. Jung mentioned the Chiron myth "wounding by one's own arrow means, first of all, the state of introversion"; For Jung, "a good half of every treatment that probes at all deeply consists in the doctor's examining himself... it is his own hurt that gives a measure of his power to heal. This, and nothing else, is the meaning of the Greek myth of the wounded physician." Jung felt that depth psychology can be potentially dangerous, because the analyst is vulnerable to being infected by his analysis by having his own wounds reopened. To avoid this, the analyst must have an ongoing relationship with the unconscious, otherwise he or she could identify with the "healer archetype", and create an inflated ego. Withdrawal of both projections may however ultimately activate the powers of the inner healer in the patients themselves. Jung’s closest colleague, Marie Louise Von Franz, said “the wounded healer IS the archetype of the Self [our wholeness, the God within] and is at the bottom of all genuine healing procedures.” Jungians warn of the dangers of inflation and splitting in the helping professions, involving projection of the 'wounded' pole of the archetype onto the patient alone, with the analyst safely separated off as 'healer'.
Although scientists and researchers had warned of a global pandemic for years, world governments were still largely unprepared for the emergence of the Covid-19 disease as it spread in a matter of weeks in early 2020. Scientists estimate that there was a 70% chance that Covid-19 would have gone extinct on its own, before reaching what's called a endemic virus (reaching the point of being embedded in the host population). As the nature of the virus became clear, countries were forced to shut down travel, businesses, and the way of life for most of the world, to a degree unprecedented in modern history. Lost global economic output measures up to $22 trillion during this time (most of 2020 through 2022). Governments and health agencies were forced to develop response plans in record time. Efforts in the United States like Operation Warp Speed sought to develop a vaccine, which was successfully released in late 2020. In the end, the pandemic became the fifth-deadliest pandemic in history and still threatens health outcomes of individuals through long covid.
Sources: en.wikipedia.org
Dihexa has been reported to activate hepatocyte growth factor/c-Met signaling in cell studies. This pathway is linked to synapse formation and neuronal remodeling. The exact molecular interactions are not fully understood.
Reverse-phase high-performance liquid chromatography is commonly used to assess purity. Mass spectrometry is used to confirm molecular identity. These methods are typical for synthetic peptides and research chemicals.
Dihexa is not approved as a drug in major jurisdictions. It is often sold as a research chemical, which is not the same as a medicine. Its legal status can vary by country and may change.
Published human clinical trial data are limited or absent. Most available evidence comes from laboratory and animal studies. Human safety and efficacy remain unresolved.